{"entity":{"type":"insider","cik":"0001777652","url":"/insider/0001777652","json_url":"/insider/0001777652.json","name":"Versant Ventures VI GP-GP, LLC","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":101,"n_filings":29,"first":"2019-11-04","last":"2025-10-02","span_basis":"filed_date"},"name_variants":[{"name":"Versant Ventures VI GP-GP, LLC","source":"filing","n_filings":29,"first_seen":"2019-11-04","last_seen":"2025-10-02"}],"transactions":[{"id":4171160,"accession":"0001193125-25-228493","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001193125-25-228493","line_url":"/filing/0001193125-25-228493#line-6","is_derivative":false,"issuer_cik":"0001687880","issuer_name":"LENZ Therapeutics, Inc.","issuer_ticker":"LENZ","issuer_name_source":null,"issuer_url":"/issuer/0001687880","owner_cik":null,"owner_name":"Versant Vantage II GP, L.P.; Versant Vantage II GP-GP, LLC; Versant Vantage II, L.P.; Versant Venture Capital VI, L.P.; Versant Venture Capital VII, L.P.; Versant Ventures VI GP, L.P.; Versant Ventures VI GP-GP, LLC; Versant Ventures VII GP, L.P.; Versant Ventures VII GP-GP, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":83066.0,"shares_display":"83,066","price_per_share":46.4068,"price_display":"46.41","price_state":"stated","total_value":3854827.2488,"total_display":"3,854,827.25","shares_owned_after":1050776.0,"shares_owned_after_display":"1,050,776","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-09-30","filed_date":"2025-10-02","scope":"insider"},{"id":4171157,"accession":"0001193125-25-228493","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001193125-25-228493","line_url":"/filing/0001193125-25-228493#line-5","is_derivative":false,"issuer_cik":"0001687880","issuer_name":"LENZ Therapeutics, Inc.","issuer_ticker":"LENZ","issuer_name_source":null,"issuer_url":"/issuer/0001687880","owner_cik":null,"owner_name":"Versant Vantage II GP, L.P.; Versant Vantage II GP-GP, LLC; Versant Vantage II, L.P.; Versant Venture Capital VI, L.P.; Versant Venture Capital VII, L.P.; Versant Ventures VI GP, L.P.; Versant Ventures VI GP-GP, LLC; Versant Ventures VII GP, L.P.; Versant Ventures VII GP-GP, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":57502.0,"shares_display":"57,502","price_per_share":46.4068,"price_display":"46.41","price_state":"stated","total_value":2668483.8136,"total_display":"2,668,483.81","shares_owned_after":764250.0,"shares_owned_after_display":"764,250","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-09-30","filed_date":"2025-10-02","scope":"insider"},{"id":4171155,"accession":"0001193125-25-228493","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001193125-25-228493","line_url":"/filing/0001193125-25-228493#line-4","is_derivative":false,"issuer_cik":"0001687880","issuer_name":"LENZ Therapeutics, Inc.","issuer_ticker":"LENZ","issuer_name_source":null,"issuer_url":"/issuer/0001687880","owner_cik":null,"owner_name":"Versant Vantage II GP, L.P.; Versant Vantage II GP-GP, LLC; Versant Vantage II, L.P.; Versant Venture Capital VI, L.P.; Versant Venture Capital VII, L.P.; Versant Ventures VI GP, L.P.; Versant Ventures VI GP-GP, LLC; Versant Ventures VII GP, L.P.; Versant Ventures VII GP-GP, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":49701.0,"shares_display":"49,701","price_per_share":45.3547,"price_display":"45.35","price_state":"stated","total_value":2254173.9447,"total_display":"2,254,173.94","shares_owned_after":1133842.0,"shares_owned_after_display":"1,133,842","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-09-30","filed_date":"2025-10-02","scope":"insider"},{"id":4171151,"accession":"0001193125-25-228493","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001193125-25-228493","line_url":"/filing/0001193125-25-228493#line-3","is_derivative":false,"issuer_cik":"0001687880","issuer_name":"LENZ Therapeutics, Inc.","issuer_ticker":"LENZ","issuer_name_source":null,"issuer_url":"/issuer/0001687880","owner_cik":null,"owner_name":"Versant Vantage II GP, L.P.; Versant Vantage II GP-GP, LLC; Versant Vantage II, L.P.; Versant Venture Capital VI, L.P.; Versant Venture Capital VII, L.P.; Versant Ventures VI GP, L.P.; Versant Ventures VI GP-GP, LLC; Versant Ventures VII GP, L.P.; Versant Ventures VII GP-GP, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":34405.0,"shares_display":"34,405","price_per_share":45.3547,"price_display":"45.35","price_state":"stated","total_value":1560428.4535,"total_display":"1,560,428.45","shares_owned_after":821752.0,"shares_owned_after_display":"821,752","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-09-30","filed_date":"2025-10-02","scope":"insider"},{"id":4171142,"accession":"0001193125-25-228493","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193125-25-228493","line_url":"/filing/0001193125-25-228493#line-2","is_derivative":false,"issuer_cik":"0001687880","issuer_name":"LENZ Therapeutics, Inc.","issuer_ticker":"LENZ","issuer_name_source":null,"issuer_url":"/issuer/0001687880","owner_cik":null,"owner_name":"Versant Vantage II GP, L.P.; Versant Vantage II GP-GP, LLC; Versant Vantage II, L.P.; Versant Venture Capital VI, L.P.; Versant Venture Capital VII, L.P.; Versant Ventures VI GP, L.P.; Versant Ventures VI GP-GP, LLC; Versant Ventures VII GP, L.P.; Versant Ventures VII GP-GP, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":177.0,"shares_display":"177","price_per_share":47.0133,"price_display":"47.01","price_state":"stated","total_value":8321.3541,"total_display":"8,321.35","shares_owned_after":1050599.0,"shares_owned_after_display":"1,050,599","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-09-30","filed_date":"2025-10-02","scope":"insider"},{"id":4171135,"accession":"0001193125-25-228493","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-25-228493","line_url":"/filing/0001193125-25-228493#line-1","is_derivative":false,"issuer_cik":"0001687880","issuer_name":"LENZ Therapeutics, Inc.","issuer_ticker":"LENZ","issuer_name_source":null,"issuer_url":"/issuer/0001687880","owner_cik":null,"owner_name":"Versant Vantage II GP, L.P.; Versant Vantage II GP-GP, LLC; Versant Vantage II, L.P.; Versant Venture Capital VI, L.P.; Versant Venture Capital VII, L.P.; Versant Ventures VI GP, L.P.; Versant Ventures VI GP-GP, LLC; Versant Ventures VII GP, L.P.; Versant Ventures VII GP-GP, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":123.0,"shares_display":"123","price_per_share":47.0133,"price_display":"47.01","price_state":"stated","total_value":5782.6359,"total_display":"5,782.64","shares_owned_after":764127.0,"shares_owned_after_display":"764,127","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-09-30","filed_date":"2025-10-02","scope":"insider"},{"id":5025160,"accession":"0001193125-25-213445","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193125-25-213445","line_url":"/filing/0001193125-25-213445#line-2","is_derivative":false,"issuer_cik":"0001687880","issuer_name":"LAVA Therapeutics NV","issuer_ticker":"LVTX","issuer_name_source":null,"issuer_url":"/issuer/0001687880","owner_cik":null,"owner_name":"Versant Vantage I GP, L.P.; Versant Vantage I GP-GP, LLC; Versant Vantage I, L.P.; Versant Venture Capital VI, L.P.; Versant Ventures VI GP, L.P.; Versant Ventures VI GP-GP, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2370533.0,"shares_display":"2,370,533","price_per_share":1.4014,"price_display":"1.40","price_state":"stated","total_value":3322064.9462,"total_display":"3,322,064.95","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-09-19","filed_date":"2025-09-23","scope":"insider"},{"id":5025155,"accession":"0001193125-25-213445","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-25-213445","line_url":"/filing/0001193125-25-213445#line-1","is_derivative":false,"issuer_cik":"0001687880","issuer_name":"LAVA Therapeutics NV","issuer_ticker":"LVTX","issuer_name_source":null,"issuer_url":"/issuer/0001687880","owner_cik":null,"owner_name":"Versant Vantage I GP, L.P.; Versant Vantage I GP-GP, LLC; Versant Vantage I, L.P.; Versant Venture Capital VI, L.P.; Versant Ventures VI GP, L.P.; Versant Ventures VI GP-GP, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":532870.0,"shares_display":"532,870","price_per_share":1.4014,"price_display":"1.40","price_state":"stated","total_value":746764.018,"total_display":"746,764.02","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-09-19","filed_date":"2025-09-23","scope":"insider"},{"id":4990228,"accession":"0001193125-25-207677","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001193125-25-207677","line_url":"/filing/0001193125-25-207677#line-6","is_derivative":false,"issuer_cik":"0001687880","issuer_name":"LAVA Therapeutics NV","issuer_ticker":"LVTX","issuer_name_source":null,"issuer_url":"/issuer/0001687880","owner_cik":null,"owner_name":"Versant Vantage I GP, L.P.; Versant Vantage I GP-GP, LLC; Versant Vantage I, L.P.; Versant Venture Capital VI, L.P.; Versant Ventures VI GP, L.P.; Versant Ventures VI GP-GP, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":366111.0,"shares_display":"366,111","price_per_share":1.4418,"price_display":"1.44","price_state":"stated","total_value":527858.8398,"total_display":"527,858.84","shares_owned_after":2370533.0,"shares_owned_after_display":"2,370,533","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-09-18","filed_date":"2025-09-18","scope":"insider"},{"id":4990222,"accession":"0001193125-25-207677","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001193125-25-207677","line_url":"/filing/0001193125-25-207677#line-5","is_derivative":false,"issuer_cik":"0001687880","issuer_name":"LAVA Therapeutics NV","issuer_ticker":"LVTX","issuer_name_source":null,"issuer_url":"/issuer/0001687880","owner_cik":null,"owner_name":"Versant Vantage I GP, L.P.; Versant Vantage I GP-GP, LLC; Versant Vantage I, L.P.; Versant Venture Capital VI, L.P.; Versant Ventures VI GP, L.P.; Versant Ventures VI GP-GP, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":228791.0,"shares_display":"228,791","price_per_share":1.4418,"price_display":"1.44","price_state":"stated","total_value":329870.8638,"total_display":"329,870.86","shares_owned_after":532870.0,"shares_owned_after_display":"532,870","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-09-18","filed_date":"2025-09-18","scope":"insider"},{"id":4456153,"accession":"0001193125-25-211363","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001193125-25-211363","line_url":"/filing/0001193125-25-211363#line-6","is_derivative":false,"issuer_cik":"0001687880","issuer_name":"LENZ Therapeutics, Inc.","issuer_ticker":"LENZ","issuer_name_source":null,"issuer_url":"/issuer/0001687880","owner_cik":null,"owner_name":"Versant Vantage II GP, L.P.; Versant Vantage II GP-GP, LLC; Versant Vantage II, L.P.; Versant Venture Capital VI, L.P.; Versant Venture Capital VII, L.P.; Versant Ventures VI GP, L.P.; Versant Ventures VI GP-GP, LLC; Versant Ventures VII GP, L.P.; Versant Ventures VII GP-GP, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":49479.0,"shares_display":"49,479","price_per_share":41.5908,"price_display":"41.59","price_state":"stated","total_value":2057871.1932,"total_display":"2,057,871.19","shares_owned_after":1224718.0,"shares_owned_after_display":"1,224,718","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-09-18","filed_date":"2025-09-22","scope":"insider"},{"id":4456148,"accession":"0001193125-25-211363","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001193125-25-211363","line_url":"/filing/0001193125-25-211363#line-5","is_derivative":false,"issuer_cik":"0001687880","issuer_name":"LENZ Therapeutics, Inc.","issuer_ticker":"LENZ","issuer_name_source":null,"issuer_url":"/issuer/0001687880","owner_cik":null,"owner_name":"Versant Vantage II GP, L.P.; Versant Vantage II GP-GP, LLC; Versant Vantage II, L.P.; Versant Venture Capital VI, L.P.; Versant Venture Capital VII, L.P.; Versant Ventures VI GP, L.P.; Versant Ventures VI GP-GP, LLC; Versant Ventures VII GP, L.P.; Versant Ventures VII GP-GP, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":40907.0,"shares_display":"40,907","price_per_share":43.0038,"price_display":"43.00","price_state":"stated","total_value":1759156.4466,"total_display":"1,759,156.45","shares_owned_after":1183811.0,"shares_owned_after_display":"1,183,811","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-09-18","filed_date":"2025-09-22","scope":"insider"},{"id":4456146,"accession":"0001193125-25-211363","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001193125-25-211363","line_url":"/filing/0001193125-25-211363#line-4","is_derivative":false,"issuer_cik":"0001687880","issuer_name":"LENZ Therapeutics, Inc.","issuer_ticker":"LENZ","issuer_name_source":null,"issuer_url":"/issuer/0001687880","owner_cik":null,"owner_name":"Versant Vantage II GP, L.P.; Versant Vantage II GP-GP, LLC; Versant Vantage II, L.P.; Versant Venture Capital VI, L.P.; Versant Venture Capital VII, L.P.; Versant Ventures VI GP, L.P.; Versant Ventures VI GP-GP, LLC; Versant Ventures VII GP, L.P.; Versant Ventures VII GP-GP, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":24370.0,"shares_display":"24,370","price_per_share":41.5908,"price_display":"41.59","price_state":"stated","total_value":1013567.796,"total_display":"1,013,567.80","shares_owned_after":876437.0,"shares_owned_after_display":"876,437","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-09-18","filed_date":"2025-09-22","scope":"insider"},{"id":4456142,"accession":"0001193125-25-211363","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001193125-25-211363","line_url":"/filing/0001193125-25-211363#line-3","is_derivative":false,"issuer_cik":"0001687880","issuer_name":"LENZ Therapeutics, Inc.","issuer_ticker":"LENZ","issuer_name_source":null,"issuer_url":"/issuer/0001687880","owner_cik":null,"owner_name":"Versant Vantage II GP, L.P.; Versant Vantage II GP-GP, LLC; Versant Vantage II, L.P.; Versant Venture Capital VI, L.P.; Versant Venture Capital VII, L.P.; Versant Ventures VI GP, L.P.; Versant Ventures VI GP-GP, LLC; Versant Ventures VII GP, L.P.; Versant Ventures VII GP-GP, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20148.0,"shares_display":"20,148","price_per_share":43.0038,"price_display":"43.00","price_state":"stated","total_value":866440.5624,"total_display":"866,440.56","shares_owned_after":856289.0,"shares_owned_after_display":"856,289","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-09-18","filed_date":"2025-09-22","scope":"insider"},{"id":4456136,"accession":"0001193125-25-211363","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193125-25-211363","line_url":"/filing/0001193125-25-211363#line-2","is_derivative":false,"issuer_cik":"0001687880","issuer_name":"LENZ Therapeutics, Inc.","issuer_ticker":"LENZ","issuer_name_source":null,"issuer_url":"/issuer/0001687880","owner_cik":null,"owner_name":"Versant Vantage II GP, L.P.; Versant Vantage II GP-GP, LLC; Versant Vantage II, L.P.; Versant Venture Capital VI, L.P.; Versant Venture Capital VII, L.P.; Versant Ventures VI GP, L.P.; Versant Ventures VI GP-GP, LLC; Versant Ventures VII GP, L.P.; Versant Ventures VII GP-GP, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":268.0,"shares_display":"268","price_per_share":43.3,"price_display":"43.30","price_state":"stated","total_value":11604.4,"total_display":"11,604.40","shares_owned_after":1183543.0,"shares_owned_after_display":"1,183,543","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-09-18","filed_date":"2025-09-22","scope":"insider"},{"id":4456132,"accession":"0001193125-25-211363","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-25-211363","line_url":"/filing/0001193125-25-211363#line-1","is_derivative":false,"issuer_cik":"0001687880","issuer_name":"LENZ Therapeutics, Inc.","issuer_ticker":"LENZ","issuer_name_source":null,"issuer_url":"/issuer/0001687880","owner_cik":null,"owner_name":"Versant Vantage II GP, L.P.; Versant Vantage II GP-GP, LLC; Versant Vantage II, L.P.; Versant Venture Capital VI, L.P.; Versant Venture Capital VII, L.P.; Versant Ventures VI GP, L.P.; Versant Ventures VI GP-GP, LLC; Versant Ventures VII GP, L.P.; Versant Ventures VII GP-GP, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":132.0,"shares_display":"132","price_per_share":43.3,"price_display":"43.30","price_state":"stated","total_value":5715.6,"total_display":"5,715.60","shares_owned_after":856157.0,"shares_owned_after_display":"856,157","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-09-18","filed_date":"2025-09-22","scope":"insider"},{"id":4990217,"accession":"0001193125-25-207677","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001193125-25-207677","line_url":"/filing/0001193125-25-207677#line-4","is_derivative":false,"issuer_cik":"0001687880","issuer_name":"LAVA Therapeutics NV","issuer_ticker":"LVTX","issuer_name_source":null,"issuer_url":"/issuer/0001687880","owner_cik":null,"owner_name":"Versant Vantage I GP, L.P.; Versant Vantage I GP-GP, LLC; Versant Vantage I, L.P.; Versant Venture Capital VI, L.P.; Versant Ventures VI GP, L.P.; Versant Ventures VI GP-GP, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":362806.0,"shares_display":"362,806","price_per_share":1.4892,"price_display":"1.49","price_state":"stated","total_value":540290.6952,"total_display":"540,290.70","shares_owned_after":2736644.0,"shares_owned_after_display":"2,736,644","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-09-17","filed_date":"2025-09-18","scope":"insider"},{"id":4990211,"accession":"0001193125-25-207677","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001193125-25-207677","line_url":"/filing/0001193125-25-207677#line-3","is_derivative":false,"issuer_cik":"0001687880","issuer_name":"LAVA Therapeutics NV","issuer_ticker":"LVTX","issuer_name_source":null,"issuer_url":"/issuer/0001687880","owner_cik":null,"owner_name":"Versant Vantage I GP, L.P.; Versant Vantage I GP-GP, LLC; Versant Vantage I, L.P.; Versant Venture Capital VI, L.P.; Versant Ventures VI GP, L.P.; Versant Ventures VI GP-GP, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":226726.0,"shares_display":"226,726","price_per_share":1.4892,"price_display":"1.49","price_state":"stated","total_value":337640.3592,"total_display":"337,640.36","shares_owned_after":761661.0,"shares_owned_after_display":"761,661","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-09-17","filed_date":"2025-09-18","scope":"insider"},{"id":4990207,"accession":"0001193125-25-207677","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193125-25-207677","line_url":"/filing/0001193125-25-207677#line-2","is_derivative":false,"issuer_cik":"0001687880","issuer_name":"LAVA Therapeutics NV","issuer_ticker":"LVTX","issuer_name_source":null,"issuer_url":"/issuer/0001687880","owner_cik":null,"owner_name":"Versant Vantage I GP, L.P.; Versant Vantage I GP-GP, LLC; Versant Vantage I, L.P.; Versant Venture Capital VI, L.P.; Versant Ventures VI GP, L.P.; Versant Ventures VI GP-GP, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":307707.0,"shares_display":"307,707","price_per_share":1.5332,"price_display":"1.53","price_state":"stated","total_value":471776.3724,"total_display":"471,776.37","shares_owned_after":3099450.0,"shares_owned_after_display":"3,099,450","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-09-16","filed_date":"2025-09-18","scope":"insider"},{"id":4990202,"accession":"0001193125-25-207677","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-25-207677","line_url":"/filing/0001193125-25-207677#line-1","is_derivative":false,"issuer_cik":"0001687880","issuer_name":"LAVA Therapeutics NV","issuer_ticker":"LVTX","issuer_name_source":null,"issuer_url":"/issuer/0001687880","owner_cik":null,"owner_name":"Versant Vantage I GP, L.P.; Versant Vantage I GP-GP, LLC; Versant Vantage I, L.P.; Versant Venture Capital VI, L.P.; Versant Ventures VI GP, L.P.; Versant Ventures VI GP-GP, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":192293.0,"shares_display":"192,293","price_per_share":1.5332,"price_display":"1.53","price_state":"stated","total_value":294823.6276,"total_display":"294,823.63","shares_owned_after":988387.0,"shares_owned_after_display":"988,387","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-09-16","filed_date":"2025-09-18","scope":"insider"},{"id":4419379,"accession":"0000950170-25-111529","txn_seq":12,"anchor":"line-12","filing_url":"/filing/0000950170-25-111529","line_url":"/filing/0000950170-25-111529#line-12","is_derivative":false,"issuer_cik":"0001687880","issuer_name":"LENZ Therapeutics, Inc.","issuer_ticker":"LENZ","issuer_name_source":null,"issuer_url":"/issuer/0001687880","owner_cik":null,"owner_name":"Versant Vantage II GP, L.P.; Versant Vantage II GP-GP, LLC; Versant Vantage II, L.P.; Versant Venture Capital VI, L.P.; Versant Venture Capital VII, L.P.; Versant Ventures VI GP, L.P.; Versant Ventures VI GP-GP, LLC; Versant Ventures VII GP, L.P.; Versant Ventures VII GP-GP, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":43978.0,"shares_display":"43,978","price_per_share":38.9744,"price_display":"38.97","price_state":"stated","total_value":1714016.1632,"total_display":"1,714,016.16","shares_owned_after":1277662.0,"shares_owned_after_display":"1,277,662","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-08-26","filed_date":"2025-08-26","scope":"insider"},{"id":4419375,"accession":"0000950170-25-111529","txn_seq":11,"anchor":"line-11","filing_url":"/filing/0000950170-25-111529","line_url":"/filing/0000950170-25-111529#line-11","is_derivative":false,"issuer_cik":"0001687880","issuer_name":"LENZ Therapeutics, Inc.","issuer_ticker":"LENZ","issuer_name_source":null,"issuer_url":"/issuer/0001687880","owner_cik":null,"owner_name":"Versant Vantage II GP, L.P.; Versant Vantage II GP-GP, LLC; Versant Vantage II, L.P.; Versant Venture Capital VI, L.P.; Versant Venture Capital VII, L.P.; Versant Ventures VI GP, L.P.; Versant Ventures VI GP-GP, LLC; Versant Ventures VII GP, L.P.; Versant Ventures VII GP-GP, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":21661.0,"shares_display":"21,661","price_per_share":38.9744,"price_display":"38.97","price_state":"stated","total_value":844224.4784,"total_display":"844,224.48","shares_owned_after":902514.0,"shares_owned_after_display":"902,514","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-08-26","filed_date":"2025-08-26","scope":"insider"},{"id":4419367,"accession":"0000950170-25-111529","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0000950170-25-111529","line_url":"/filing/0000950170-25-111529#line-10","is_derivative":false,"issuer_cik":"0001687880","issuer_name":"LENZ Therapeutics, Inc.","issuer_ticker":"LENZ","issuer_name_source":null,"issuer_url":"/issuer/0001687880","owner_cik":null,"owner_name":"Versant Vantage II GP, L.P.; Versant Vantage II GP-GP, LLC; Versant Vantage II, L.P.; Versant Venture Capital VI, L.P.; Versant Venture Capital VII, L.P.; Versant Ventures VI GP, L.P.; Versant Ventures VI GP-GP, LLC; Versant Ventures VII GP, L.P.; Versant Ventures VII GP-GP, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3465.0,"shares_display":"3,465","price_per_share":39.5022,"price_display":"39.50","price_state":"stated","total_value":136875.123,"total_display":"136,875.12","shares_owned_after":1274197.0,"shares_owned_after_display":"1,274,197","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-08-26","filed_date":"2025-08-26","scope":"insider"},{"id":4419363,"accession":"0000950170-25-111529","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0000950170-25-111529","line_url":"/filing/0000950170-25-111529#line-9","is_derivative":false,"issuer_cik":"0001687880","issuer_name":"LENZ Therapeutics, Inc.","issuer_ticker":"LENZ","issuer_name_source":null,"issuer_url":"/issuer/0001687880","owner_cik":null,"owner_name":"Versant Vantage II GP, L.P.; Versant Vantage II GP-GP, LLC; Versant Vantage II, L.P.; Versant Venture Capital VI, L.P.; Versant Venture Capital VII, L.P.; Versant Ventures VI GP, L.P.; Versant Ventures VI GP-GP, LLC; Versant Ventures VII GP, L.P.; Versant Ventures VII GP-GP, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1707.0,"shares_display":"1,707","price_per_share":39.5022,"price_display":"39.50","price_state":"stated","total_value":67430.2554,"total_display":"67,430.26","shares_owned_after":900807.0,"shares_owned_after_display":"900,807","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-08-26","filed_date":"2025-08-26","scope":"insider"},{"id":4419360,"accession":"0000950170-25-111529","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0000950170-25-111529","line_url":"/filing/0000950170-25-111529#line-8","is_derivative":false,"issuer_cik":"0001687880","issuer_name":"LENZ Therapeutics, Inc.","issuer_ticker":"LENZ","issuer_name_source":null,"issuer_url":"/issuer/0001687880","owner_cik":null,"owner_name":"Versant Vantage II GP, L.P.; Versant Vantage II GP-GP, LLC; Versant Vantage II, L.P.; Versant Venture Capital VI, L.P.; Versant Venture Capital VII, L.P.; Versant Ventures VI GP, L.P.; Versant Ventures VI GP-GP, LLC; Versant Ventures VII GP, L.P.; Versant Ventures VII GP-GP, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50270.0,"shares_display":"50,270","price_per_share":39.5255,"price_display":"39.53","price_state":"stated","total_value":1986946.885,"total_display":"1,986,946.88","shares_owned_after":1323789.0,"shares_owned_after_display":"1,323,789","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-08-25","filed_date":"2025-08-26","scope":"insider"},{"id":4419357,"accession":"0000950170-25-111529","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0000950170-25-111529","line_url":"/filing/0000950170-25-111529#line-7","is_derivative":false,"issuer_cik":"0001687880","issuer_name":"LENZ Therapeutics, Inc.","issuer_ticker":"LENZ","issuer_name_source":null,"issuer_url":"/issuer/0001687880","owner_cik":null,"owner_name":"Versant Vantage II GP, L.P.; Versant Vantage II GP-GP, LLC; Versant Vantage II, L.P.; Versant Venture Capital VI, L.P.; Versant Venture Capital VII, L.P.; Versant Ventures VI GP, L.P.; Versant Ventures VI GP-GP, LLC; Versant Ventures VII GP, L.P.; Versant Ventures VII GP-GP, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":24760.0,"shares_display":"24,760","price_per_share":39.5255,"price_display":"39.53","price_state":"stated","total_value":978651.38,"total_display":"978,651.38","shares_owned_after":925233.0,"shares_owned_after_display":"925,233","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-08-25","filed_date":"2025-08-26","scope":"insider"},{"id":4419353,"accession":"0000950170-25-111529","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0000950170-25-111529","line_url":"/filing/0000950170-25-111529#line-6","is_derivative":false,"issuer_cik":"0001687880","issuer_name":"LENZ Therapeutics, Inc.","issuer_ticker":"LENZ","issuer_name_source":null,"issuer_url":"/issuer/0001687880","owner_cik":null,"owner_name":"Versant Vantage II GP, L.P.; Versant Vantage II GP-GP, LLC; Versant Vantage II, L.P.; Versant Venture Capital VI, L.P.; Versant Venture Capital VII, L.P.; Versant Ventures VI GP, L.P.; Versant Ventures VI GP-GP, LLC; Versant Ventures VII GP, L.P.; Versant Ventures VII GP-GP, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2149.0,"shares_display":"2,149","price_per_share":39.9212,"price_display":"39.92","price_state":"stated","total_value":85790.6588,"total_display":"85,790.66","shares_owned_after":1321640.0,"shares_owned_after_display":"1,321,640","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-08-25","filed_date":"2025-08-26","scope":"insider"},{"id":4419343,"accession":"0000950170-25-111529","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0000950170-25-111529","line_url":"/filing/0000950170-25-111529#line-5","is_derivative":false,"issuer_cik":"0001687880","issuer_name":"LENZ Therapeutics, Inc.","issuer_ticker":"LENZ","issuer_name_source":null,"issuer_url":"/issuer/0001687880","owner_cik":null,"owner_name":"Versant Vantage II GP, L.P.; Versant Vantage II GP-GP, LLC; Versant Vantage II, L.P.; Versant Venture Capital VI, L.P.; Versant Venture Capital VII, L.P.; Versant Ventures VI GP, L.P.; Versant Ventures VI GP-GP, LLC; Versant Ventures VII GP, L.P.; Versant Ventures VII GP-GP, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1058.0,"shares_display":"1,058","price_per_share":39.9212,"price_display":"39.92","price_state":"stated","total_value":42236.6296,"total_display":"42,236.63","shares_owned_after":924175.0,"shares_owned_after_display":"924,175","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-08-25","filed_date":"2025-08-26","scope":"insider"},{"id":4419339,"accession":"0000950170-25-111529","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000950170-25-111529","line_url":"/filing/0000950170-25-111529#line-4","is_derivative":false,"issuer_cik":"0001687880","issuer_name":"LENZ Therapeutics, Inc.","issuer_ticker":"LENZ","issuer_name_source":null,"issuer_url":"/issuer/0001687880","owner_cik":null,"owner_name":"Versant Vantage II GP, L.P.; Versant Vantage II GP-GP, LLC; Versant Vantage II, L.P.; Versant Venture Capital VI, L.P.; Versant Venture Capital VII, L.P.; Versant Ventures VI GP, L.P.; Versant Ventures VI GP-GP, LLC; Versant Ventures VII GP, L.P.; Versant Ventures VII GP-GP, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20493.0,"shares_display":"20,493","price_per_share":40.0297,"price_display":"40.03","price_state":"stated","total_value":820328.6421,"total_display":"820,328.64","shares_owned_after":1379727.0,"shares_owned_after_display":"1,379,727","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-08-22","filed_date":"2025-08-26","scope":"insider"},{"id":4419335,"accession":"0000950170-25-111529","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000950170-25-111529","line_url":"/filing/0000950170-25-111529#line-3","is_derivative":false,"issuer_cik":"0001687880","issuer_name":"LENZ Therapeutics, Inc.","issuer_ticker":"LENZ","issuer_name_source":null,"issuer_url":"/issuer/0001687880","owner_cik":null,"owner_name":"Versant Vantage II GP, L.P.; Versant Vantage II GP-GP, LLC; Versant Vantage II, L.P.; Versant Venture Capital VI, L.P.; Versant Venture Capital VII, L.P.; Versant Ventures VI GP, L.P.; Versant Ventures VI GP-GP, LLC; Versant Ventures VII GP, L.P.; Versant Ventures VII GP-GP, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10076.0,"shares_display":"10,076","price_per_share":40.0297,"price_display":"40.03","price_state":"stated","total_value":403339.2572,"total_display":"403,339.26","shares_owned_after":952802.0,"shares_owned_after_display":"952,802","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-08-22","filed_date":"2025-08-26","scope":"insider"},{"id":4419331,"accession":"0000950170-25-111529","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-25-111529","line_url":"/filing/0000950170-25-111529#line-2","is_derivative":false,"issuer_cik":"0001687880","issuer_name":"LENZ Therapeutics, Inc.","issuer_ticker":"LENZ","issuer_name_source":null,"issuer_url":"/issuer/0001687880","owner_cik":null,"owner_name":"Versant Vantage II GP, L.P.; Versant Vantage II GP-GP, LLC; Versant Vantage II, L.P.; Versant Venture Capital VI, L.P.; Versant Venture Capital VII, L.P.; Versant Ventures VI GP, L.P.; Versant Ventures VI GP-GP, LLC; Versant Ventures VII GP, L.P.; Versant Ventures VII GP-GP, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5668.0,"shares_display":"5,668","price_per_share":40.5899,"price_display":"40.59","price_state":"stated","total_value":230063.5532,"total_display":"230,063.55","shares_owned_after":1374059.0,"shares_owned_after_display":"1,374,059","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-08-22","filed_date":"2025-08-26","scope":"insider"},{"id":4419324,"accession":"0000950170-25-111529","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-25-111529","line_url":"/filing/0000950170-25-111529#line-1","is_derivative":false,"issuer_cik":"0001687880","issuer_name":"LENZ Therapeutics, Inc.","issuer_ticker":"LENZ","issuer_name_source":null,"issuer_url":"/issuer/0001687880","owner_cik":null,"owner_name":"Versant Vantage II GP, L.P.; Versant Vantage II GP-GP, LLC; Versant Vantage II, L.P.; Versant Venture Capital VI, L.P.; Versant Venture Capital VII, L.P.; Versant Ventures VI GP, L.P.; Versant Ventures VI GP-GP, LLC; Versant Ventures VII GP, L.P.; Versant Ventures VII GP-GP, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2809.0,"shares_display":"2,809","price_per_share":40.5899,"price_display":"40.59","price_state":"stated","total_value":114017.0291,"total_display":"114,017.03","shares_owned_after":949993.0,"shares_owned_after_display":"949,993","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-08-22","filed_date":"2025-08-26","scope":"insider"},{"id":4947847,"accession":"0000950170-25-110163","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000950170-25-110163","line_url":"/filing/0000950170-25-110163#line-4","is_derivative":false,"issuer_cik":"0001687880","issuer_name":"LENZ Therapeutics, Inc.","issuer_ticker":"LENZ","issuer_name_source":null,"issuer_url":"/issuer/0001687880","owner_cik":null,"owner_name":"Versant Vantage II GP, L.P.; Versant Vantage II GP-GP, LLC; Versant Vantage II, L.P.; Versant Venture Capital VI, L.P.; Versant Venture Capital VII, L.P.; Versant Ventures VI GP, L.P.; Versant Ventures VI GP-GP, LLC; Versant Ventures VII GP, L.P.; Versant Ventures VII GP-GP, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30628.0,"shares_display":"30,628","price_per_share":38.5611,"price_display":"38.56","price_state":"stated","total_value":1181049.3708,"total_display":"1,181,049.37","shares_owned_after":1400220.0,"shares_owned_after_display":"1,400,220","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-08-18","filed_date":"2025-08-19","scope":"insider"},{"id":4947841,"accession":"0000950170-25-110163","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000950170-25-110163","line_url":"/filing/0000950170-25-110163#line-3","is_derivative":false,"issuer_cik":"0001687880","issuer_name":"LENZ Therapeutics, Inc.","issuer_ticker":"LENZ","issuer_name_source":null,"issuer_url":"/issuer/0001687880","owner_cik":null,"owner_name":"Versant Vantage II GP, L.P.; Versant Vantage II GP-GP, LLC; Versant Vantage II, L.P.; Versant Venture Capital VI, L.P.; Versant Venture Capital VII, L.P.; Versant Ventures VI GP, L.P.; Versant Ventures VI GP-GP, LLC; Versant Ventures VII GP, L.P.; Versant Ventures VII GP-GP, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15085.0,"shares_display":"15,085","price_per_share":38.5611,"price_display":"38.56","price_state":"stated","total_value":581694.1935,"total_display":"581,694.19","shares_owned_after":962878.0,"shares_owned_after_display":"962,878","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-08-18","filed_date":"2025-08-19","scope":"insider"},{"id":4947836,"accession":"0000950170-25-110163","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-25-110163","line_url":"/filing/0000950170-25-110163#line-2","is_derivative":false,"issuer_cik":"0001687880","issuer_name":"LENZ Therapeutics, Inc.","issuer_ticker":"LENZ","issuer_name_source":null,"issuer_url":"/issuer/0001687880","owner_cik":null,"owner_name":"Versant Vantage II GP, L.P.; Versant Vantage II GP-GP, LLC; Versant Vantage II, L.P.; Versant Venture Capital VI, L.P.; Versant Venture Capital VII, L.P.; Versant Ventures VI GP, L.P.; Versant Ventures VI GP-GP, LLC; Versant Ventures VII GP, L.P.; Versant Ventures VII GP-GP, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":145051.0,"shares_display":"145,051","price_per_share":39.5,"price_display":"39.50","price_state":"stated","total_value":5729514.5,"total_display":"5,729,514.50","shares_owned_after":1430848.0,"shares_owned_after_display":"1,430,848","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-08-15","filed_date":"2025-08-19","scope":"insider"},{"id":4947831,"accession":"0000950170-25-110163","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-25-110163","line_url":"/filing/0000950170-25-110163#line-1","is_derivative":false,"issuer_cik":"0001687880","issuer_name":"LENZ Therapeutics, Inc.","issuer_ticker":"LENZ","issuer_name_source":null,"issuer_url":"/issuer/0001687880","owner_cik":null,"owner_name":"Versant Vantage II GP, L.P.; Versant Vantage II GP-GP, LLC; Versant Vantage II, L.P.; Versant Venture Capital VI, L.P.; Versant Venture Capital VII, L.P.; Versant Ventures VI GP, L.P.; Versant Ventures VI GP-GP, LLC; Versant Ventures VII GP, L.P.; Versant Ventures VII GP-GP, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":69949.0,"shares_display":"69,949","price_per_share":39.5,"price_display":"39.50","price_state":"stated","total_value":2762985.5,"total_display":"2,762,985.50","shares_owned_after":977963.0,"shares_owned_after_display":"977,963","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-08-15","filed_date":"2025-08-19","scope":"insider"},{"id":5198366,"accession":"0000950170-25-095616","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-25-095616","line_url":"/filing/0000950170-25-095616#line-1","is_derivative":false,"issuer_cik":"0001687880","issuer_name":"LENZ Therapeutics, Inc.","issuer_ticker":"LENZ","issuer_name_source":null,"issuer_url":"/issuer/0001687880","owner_cik":null,"owner_name":"Versant Vantage II GP, L.P.; Versant Vantage II GP-GP, LLC; Versant Vantage II, L.P.; Versant Venture Capital VI, L.P.; Versant Venture Capital VII, L.P.; Versant Ventures VI GP, L.P.; Versant Ventures VI GP-GP, LLC; Versant Ventures VII GP, L.P.; Versant Ventures VII GP-GP, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":191376.0,"shares_display":"191,376","price_per_share":34.0,"price_display":"34.00","price_state":"stated","total_value":6506784.0,"total_display":"6,506,784.00","shares_owned_after":1575899.0,"shares_owned_after_display":"1,575,899","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-07-10","filed_date":"2025-07-14","scope":"insider"},{"id":4836463,"accession":"0000950170-25-092373","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-25-092373","line_url":"/filing/0000950170-25-092373#line-1","is_derivative":false,"issuer_cik":"0001687880","issuer_name":"LENZ Therapeutics, Inc.","issuer_ticker":"LENZ","issuer_name_source":null,"issuer_url":"/issuer/0001687880","owner_cik":null,"owner_name":"Versant Vantage II GP, L.P.; Versant Vantage II GP-GP, LLC; Versant Vantage II, L.P.; Versant Venture Capital VI, L.P.; Versant Venture Capital VII, L.P.; Versant Ventures VI GP, L.P.; Versant Ventures VI GP-GP, LLC; Versant Ventures VII GP, L.P.; Versant Ventures VII GP-GP, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200000.0,"shares_display":"200,000","price_per_share":30.465,"price_display":"30.46","price_state":"stated","total_value":6093000.0,"total_display":"6,093,000.00","shares_owned_after":1767275.0,"shares_owned_after_display":"1,767,275","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-06-27","filed_date":"2025-07-01","scope":"insider"},{"id":4063046,"accession":"0000950170-25-088604","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000950170-25-088604","line_url":"/filing/0000950170-25-088604#line-3","is_derivative":false,"issuer_cik":"0001687880","issuer_name":"LENZ Therapeutics, Inc.","issuer_ticker":"LENZ","issuer_name_source":null,"issuer_url":"/issuer/0001687880","owner_cik":null,"owner_name":"Versant Vantage II GP, L.P.; Versant Vantage II GP-GP, LLC; Versant Vantage II, L.P.; Versant Venture Capital VI, L.P.; Versant Venture Capital VII, L.P.; Versant Ventures VI GP, L.P.; Versant Ventures VI GP-GP, LLC; Versant Ventures VII GP, L.P.; Versant Ventures VII GP-GP, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":133924.0,"shares_display":"133,924","price_per_share":30.25,"price_display":"30.25","price_state":"stated","total_value":4051201.0,"total_display":"4,051,201.00","shares_owned_after":1967275.0,"shares_owned_after_display":"1,967,275","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-06-20","filed_date":"2025-06-20","scope":"insider"},{"id":4063043,"accession":"0000950170-25-088604","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-25-088604","line_url":"/filing/0000950170-25-088604#line-2","is_derivative":false,"issuer_cik":"0001687880","issuer_name":"LENZ Therapeutics, Inc.","issuer_ticker":"LENZ","issuer_name_source":null,"issuer_url":"/issuer/0001687880","owner_cik":null,"owner_name":"Versant Vantage II GP, L.P.; Versant Vantage II GP-GP, LLC; Versant Vantage II, L.P.; Versant Venture Capital VI, L.P.; Versant Venture Capital VII, L.P.; Versant Ventures VI GP, L.P.; Versant Ventures VI GP-GP, LLC; Versant Ventures VII GP, L.P.; Versant Ventures VII GP-GP, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100877.0,"shares_display":"100,877","price_per_share":30.35,"price_display":"30.35","price_state":"stated","total_value":3061616.95,"total_display":"3,061,616.95","shares_owned_after":1047912.0,"shares_owned_after_display":"1,047,912","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-06-20","filed_date":"2025-06-20","scope":"insider"},{"id":4063040,"accession":"0000950170-25-088604","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-25-088604","line_url":"/filing/0000950170-25-088604#line-1","is_derivative":false,"issuer_cik":"0001687880","issuer_name":"LENZ Therapeutics, Inc.","issuer_ticker":"LENZ","issuer_name_source":null,"issuer_url":"/issuer/0001687880","owner_cik":null,"owner_name":"Versant Vantage II GP, L.P.; Versant Vantage II GP-GP, LLC; Versant Vantage II, L.P.; Versant Venture Capital VI, L.P.; Versant Venture Capital VII, L.P.; Versant Ventures VI GP, L.P.; Versant Ventures VI GP-GP, LLC; Versant Ventures VII GP, L.P.; Versant Ventures VII GP-GP, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100000.0,"shares_display":"100,000","price_per_share":29.95,"price_display":"29.95","price_state":"stated","total_value":2995000.0,"total_display":"2,995,000.00","shares_owned_after":1148789.0,"shares_owned_after_display":"1,148,789","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-06-18","filed_date":"2025-06-20","scope":"insider"},{"id":4264480,"accession":"0000950170-25-085490","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-25-085490","line_url":"/filing/0000950170-25-085490#line-1","is_derivative":false,"issuer_cik":"0001687880","issuer_name":"LENZ Therapeutics, Inc.","issuer_ticker":"LENZ","issuer_name_source":null,"issuer_url":"/issuer/0001687880","owner_cik":null,"owner_name":"Versant Vantage II GP, L.P.; Versant Vantage II GP-GP, LLC; Versant Vantage II, L.P.; Versant Venture Capital VI, L.P.; Versant Venture Capital VII, L.P.; Versant Ventures VI GP, L.P.; Versant Ventures VI GP-GP, LLC; Versant Ventures VII GP, L.P.; Versant Ventures VII GP-GP, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":350000.0,"shares_display":"350,000","price_per_share":29.0,"price_display":"29.00","price_state":"stated","total_value":10150000.0,"total_display":"10,150,000.00","shares_owned_after":1248789.0,"shares_owned_after_display":"1,248,789","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-06-10","filed_date":"2025-06-12","scope":"insider"},{"id":3112863,"accession":"0000950170-24-119051","txn_seq":13,"anchor":"line-13","filing_url":"/filing/0000950170-24-119051","line_url":"/filing/0000950170-24-119051#line-13","is_derivative":false,"issuer_cik":"0001687880","issuer_name":"Monte Rosa Therapeutics, Inc.","issuer_ticker":"GLUE","issuer_name_source":null,"issuer_url":"/issuer/0001687880","owner_cik":null,"owner_name":"Versant Vantage I GP, L.P.; Versant Vantage I GP-GP, LLC; Versant Vantage I, L.P.; Versant Venture Capital VI, L.P.; Versant Ventures VI GP, L.P.; Versant Ventures VI GP-GP, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":52305.0,"shares_display":"52,305","price_per_share":9.0815,"price_display":"9.08","price_state":"stated","total_value":475007.8575,"total_display":"475,007.86","shares_owned_after":1589053.0,"shares_owned_after_display":"1,589,053","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-10-29","filed_date":"2024-10-30","scope":"insider"},{"id":3112859,"accession":"0000950170-24-119051","txn_seq":12,"anchor":"line-12","filing_url":"/filing/0000950170-24-119051","line_url":"/filing/0000950170-24-119051#line-12","is_derivative":false,"issuer_cik":"0001687880","issuer_name":"Monte Rosa Therapeutics, Inc.","issuer_ticker":"GLUE","issuer_name_source":null,"issuer_url":"/issuer/0001687880","owner_cik":null,"owner_name":"Versant Vantage I GP, L.P.; Versant Vantage I GP-GP, LLC; Versant Vantage I, L.P.; Versant Venture Capital VI, L.P.; Versant Ventures VI GP, L.P.; Versant Ventures VI GP-GP, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15600.0,"shares_display":"15,600","price_per_share":9.4098,"price_display":"9.41","price_state":"stated","total_value":146792.88,"total_display":"146,792.88","shares_owned_after":1573453.0,"shares_owned_after_display":"1,573,453","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-10-29","filed_date":"2024-10-30","scope":"insider"},{"id":3112856,"accession":"0000950170-24-119051","txn_seq":11,"anchor":"line-11","filing_url":"/filing/0000950170-24-119051","line_url":"/filing/0000950170-24-119051#line-11","is_derivative":false,"issuer_cik":"0001687880","issuer_name":"Monte Rosa Therapeutics, Inc.","issuer_ticker":"GLUE","issuer_name_source":null,"issuer_url":"/issuer/0001687880","owner_cik":null,"owner_name":"Versant Vantage I GP, L.P.; Versant Vantage I GP-GP, LLC; Versant Vantage I, L.P.; Versant Venture Capital VI, L.P.; Versant Ventures VI GP, L.P.; Versant Ventures VI GP-GP, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":89990.0,"shares_display":"89,990","price_per_share":9.6593,"price_display":"9.66","price_state":"stated","total_value":869240.407,"total_display":"869,240.41","shares_owned_after":2007948.0,"shares_owned_after_display":"2,007,948","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-10-28","filed_date":"2024-10-30","scope":"insider"},{"id":2083039,"accession":"0000950170-24-109112","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-109112","line_url":"/filing/0000950170-24-109112#line-1","is_derivative":false,"issuer_cik":"0001687880","issuer_name":"Monte Rosa Therapeutics, Inc.","issuer_ticker":"GLUE","issuer_name_source":null,"issuer_url":"/issuer/0001687880","owner_cik":null,"owner_name":"Versant Vantage I GP, L.P.; Versant Vantage I GP-GP, LLC; Versant Vantage I, L.P.; Versant Venture Capital VI, L.P.; Versant Ventures VI GP, L.P.; Versant Ventures VI GP-GP, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1132566.0,"shares_display":"1,132,566","price_per_share":6.5296,"price_display":"6.53","price_state":"stated","total_value":7395202.9536,"total_display":"7,395,202.95","shares_owned_after":5099336.0,"shares_owned_after_display":"5,099,336","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-09-20","filed_date":"2024-09-24","scope":"insider"},{"id":2897808,"accession":"0000950170-24-106532","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000950170-24-106532","line_url":"/filing/0000950170-24-106532#line-3","is_derivative":false,"issuer_cik":"0001687880","issuer_name":"Monte Rosa Therapeutics, Inc.","issuer_ticker":"GLUE","issuer_name_source":null,"issuer_url":"/issuer/0001687880","owner_cik":null,"owner_name":"Versant Vantage I GP, L.P.; Versant Vantage I GP-GP, LLC; Versant Vantage I, L.P.; Versant Venture Capital VI, L.P.; Versant Ventures VI GP, L.P.; Versant Ventures VI GP-GP, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9269.0,"shares_display":"9,269","price_per_share":6.1603,"price_display":"6.16","price_state":"stated","total_value":57099.8207,"total_display":"57,099.82","shares_owned_after":6231902.0,"shares_owned_after_display":"6,231,902","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-09-13","filed_date":"2024-09-13","scope":"insider"},{"id":2897804,"accession":"0000950170-24-106532","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-24-106532","line_url":"/filing/0000950170-24-106532#line-2","is_derivative":false,"issuer_cik":"0001687880","issuer_name":"Monte Rosa Therapeutics, Inc.","issuer_ticker":"GLUE","issuer_name_source":null,"issuer_url":"/issuer/0001687880","owner_cik":null,"owner_name":"Versant Vantage I GP, L.P.; Versant Vantage I GP-GP, LLC; Versant Vantage I, L.P.; Versant Venture Capital VI, L.P.; Versant Ventures VI GP, L.P.; Versant Ventures VI GP-GP, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16047.0,"shares_display":"16,047","price_per_share":6.0017,"price_display":"6.00","price_state":"stated","total_value":96309.2799,"total_display":"96,309.28","shares_owned_after":6241171.0,"shares_owned_after_display":"6,241,171","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-09-12","filed_date":"2024-09-13","scope":"insider"},{"id":2897797,"accession":"0000950170-24-106532","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-106532","line_url":"/filing/0000950170-24-106532#line-1","is_derivative":false,"issuer_cik":"0001687880","issuer_name":"Monte Rosa Therapeutics, Inc.","issuer_ticker":"GLUE","issuer_name_source":null,"issuer_url":"/issuer/0001687880","owner_cik":null,"owner_name":"Versant Vantage I GP, L.P.; Versant Vantage I GP-GP, LLC; Versant Vantage I, L.P.; Versant Venture Capital VI, L.P.; Versant Ventures VI GP, L.P.; Versant Ventures VI GP-GP, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":541897.0,"shares_display":"541,897","price_per_share":6.0,"price_display":"6.00","price_state":"stated","total_value":3251382.0,"total_display":"3,251,382.00","shares_owned_after":6257218.0,"shares_owned_after_display":"6,257,218","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-09-11","filed_date":"2024-09-13","scope":"insider"},{"id":2827819,"accession":"0000950170-24-095675","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-24-095675","line_url":"/filing/0000950170-24-095675#line-2","is_derivative":false,"issuer_cik":"0001456589","issuer_name":"Tempest Therapeutics, Inc.","issuer_ticker":"TPST","issuer_name_source":null,"issuer_url":"/issuer/0001456589","owner_cik":null,"owner_name":"Versant Side Fund IV, L.P.; Versant Vantage II GP, L.P.; Versant Vantage II GP-GP, LLC; Versant Vantage II, L.P.; Versant Venture Capital IV, L.P.; Versant Venture Capital VI, L.P.; Versant Ventures IV, LLC; Versant Ventures VI GP, L.P.; Versant Ventures VI GP-GP, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":387999.0,"shares_display":"387,999","price_per_share":1.1005,"price_display":"1.10","price_state":"stated","total_value":426992.8995,"total_display":"426,992.90","shares_owned_after":209941.0,"shares_owned_after_display":"209,941","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-08-12","filed_date":"2024-08-12","scope":"insider"}],"next_cursor":"2024-08-12|2827819","ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001815776","name":"LENZ Therapeutics, Inc.","url":"/issuer/0001815776","role":"Ten percent owner","n_filings":9,"first_seen":"2021-07-01","last_seen":"2025-10-02"},{"type":"issuer","type_label":"ISSUER","cik":"0001840748","name":"LAVA Therapeutics NV","url":"/issuer/0001840748","role":"Ten percent owner","n_filings":2,"first_seen":"2025-09-18","last_seen":"2025-09-23"},{"type":"issuer","type_label":"ISSUER","cik":"0001826457","name":"Monte Rosa Therapeutics, Inc.","url":"/issuer/0001826457","role":"Ten percent owner","n_filings":4,"first_seen":"2021-06-30","last_seen":"2024-10-30"},{"type":"issuer","type_label":"ISSUER","cik":"0001544227","name":"Tempest Therapeutics, Inc.","url":"/issuer/0001544227","role":"Ten percent owner","n_filings":1,"first_seen":"2024-08-12","last_seen":"2024-08-12"},{"type":"issuer","type_label":"ISSUER","cik":"0001850119","name":"Century Therapeutics, Inc.","url":"/issuer/0001850119","role":"Ten percent owner","n_filings":2,"first_seen":"2021-06-23","last_seen":"2022-08-11"},{"type":"issuer","type_label":"ISSUER","cik":"0001808158","name":"Repare Therapeutics Inc.","url":"/issuer/0001808158","role":"Ten percent owner","n_filings":2,"first_seen":"2020-06-25","last_seen":"2022-06-07"},{"type":"issuer","type_label":"ISSUER","cik":"0001720725","name":"Oyster Point Pharma, Inc.","url":"/issuer/0001720725","role":"Ten percent owner","n_filings":2,"first_seen":"2019-11-04","last_seen":"2021-10-20"},{"type":"issuer","type_label":"ISSUER","cik":"0001744659","name":"Akero Therapeutics, Inc.","url":"/issuer/0001744659","role":"Ten percent owner","n_filings":6,"first_seen":"2020-01-06","last_seen":"2020-07-10"},{"type":"issuer","type_label":"ISSUER","cik":"0001787297","name":"Passage BIO, Inc.","url":"/issuer/0001787297","role":"Ten percent owner","n_filings":1,"first_seen":"2020-03-03","last_seen":"2020-03-03"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001777652","retrieved_at":"2026-08-21T19:23:15+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}